Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil; an exploratory analysis of a randomised controlled trial

Clemens SC. et al, (2021)

"Should children be offered covid-19 vaccination?" No

Wilkinson D. et al, (2021), BMJ: British Medical Journal

Combining multiomics and drug perturbation profiles to identify muscle-specific treatments for spinal muscular atrophy.

Meijboom KE. et al, (2021), JCI Insight, 6

Safety and Immunogenicity Report from the Com-COV Study – a Single-Blind Randomised Non-Inferiority Trial Comparing Heterologous And Homologous Prime-Boost Schedules with An Adenoviral Vectored and mRNA COVID-19 Vaccine

Liu X. et al, (2021), SSRN Electronic Journal

Tolerability and Immunogenicity After a Late Second Dose or a Third Dose of ChAdOx1 nCoV-19 (AZD1222)

Flaxman A. et al, (2021), SSRN Electronic Journal

A Salmonella Typhi Controlled Human Infection Study for Assessing Correlation between Bactericidal Antibodies and Protection against Infection Induced by Typhoid Vaccination.

Jones E. et al, (2021), Microorganisms, 9

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Feng S. et al, (2021)

SARS-CoV-2 Variants and Vaccines.

Krause PR. et al, (2021), N Engl J Med

T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.

Swanson PA. et al, (2021), medRxiv

Gestational methylazoxymethanol acetate administration alters α5GABAA and NMDA receptor density: An integrated neuroimaging, behavioral and pharmacological study

Kiemes A. et al, (2021)

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.

Frater J. et al, (2021), Lancet HIV

Impaired antibody response to COVID‐19 vaccination in patients with chronic myeloid neoplasms

Chowdhury O. et al, (2021), British Journal of Haematology

Divergent trajectories of antiviral memory after SARS-Cov-2 infection

Tomic* A. et al, (2021)

Mesyl Phosphoramidate Oligonucleotides as Potential Splice Switching Agents: Impact of Backbone Structure on Activity and Intracellular Localization

HAMMOND SM. et al, (2021), Nucleic Acid Therapeutics

ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates - Authors' reply.

Voysey M. and Pollard AJ., (2021), Lancet, 397

Charting mandatory childhood vaccination policies worldwide.

Vanderslott S. and Marks T., (2021), Vaccine

Extracellular vesicles as a next-generation drug delivery platform

WOOD M. et al, (2021), Nature Nanotechnology

High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluation.

Sibley L. et al, (2021), Sci Rep, 11

Therapies in preclinical and clinical development for Angelman syndrome.

Markati T. et al, (2021), Expert Opin Investig Drugs

Injection fears and COVID-19 vaccine hesitancy

FREEMAN D., (2021), Psychological Medicine

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?